Used in neuroscience research to quantify levels of PPP1R1B protein in brain tissue and cell lysates, aiding studies on dopamine signaling pathways and synaptic plasticity. Commonly applied in investigations related to addiction, schizophrenia, and Parkinson’s disease. Enables researchers to assess changes in protein expression under different experimental conditions, such as drug exposure or genetic manipulation. Suitable for high-throughput screening in preclinical studies focusing on neuropsychiatric disorders.